These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29270748)
1. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. Li B; Xie F; Zheng FX; Jiang GS; Zeng FQ; Xiao XY J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):886-890. PubMed ID: 29270748 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Wang M; Guo C; Wang L; Luo G; Huang C; Li Y; Liu D; Zeng F; Jiang G; Xiao X Cell Death Dis; 2018 Feb; 9(2):238. PubMed ID: 29445179 [TBL] [Abstract][Full Text] [Related]
3. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101. Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857 [TBL] [Abstract][Full Text] [Related]
4. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Xie F; Li Y; Wang M; Huang C; Tao D; Zheng F; Zhang H; Zeng F; Xiao X; Jiang G Mol Cancer; 2018 Oct; 17(1):144. PubMed ID: 30285878 [TBL] [Abstract][Full Text] [Related]
6. CircRNA-100284 activates aurora kinase B by inducing methylation of HSP70 via microRNA-217 to promote proliferation of bladder cancer cells. Huang ZM; Wang H; Ji ZG J Cancer Res Clin Oncol; 2021 Mar; 147(3):703-712. PubMed ID: 33386469 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression. Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157 [TBL] [Abstract][Full Text] [Related]
8. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. Yang F; Lv LZ; Cai QC; Jiang Y World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway. Song L; Xiao Y Biochem Biophys Res Commun; 2018 Sep; 503(4):2603-2610. PubMed ID: 30139516 [TBL] [Abstract][Full Text] [Related]
10. Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation. Dai X; Chen C; Yang Q; Xue J; Chen X; Sun B; Luo F; Liu X; Xiao T; Xu H; Sun Q; Zhang A; Liu Q Cell Death Dis; 2018 May; 9(5):454. PubMed ID: 29674685 [TBL] [Abstract][Full Text] [Related]
11. Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis. Xue J; Liu Y; Luo F; Lu X; Xu H; Liu X; Lu L; Yang Q; Chen C; Fan W; Liu Q Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):753-763. PubMed ID: 28062277 [TBL] [Abstract][Full Text] [Related]
12. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567 [TBL] [Abstract][Full Text] [Related]
13. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression. Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261 [TBL] [Abstract][Full Text] [Related]
14. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Zhong Z; Lv M; Chen J Sci Rep; 2016 Aug; 6():30919. PubMed ID: 27484176 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis. Wang H; Xiao Y; Wu L; Ma D Int J Oncol; 2018 Mar; 52(3):743-754. PubMed ID: 29431182 [TBL] [Abstract][Full Text] [Related]
16. Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells. Chen Y; Xie H; Zou Y; Lai X; Ma L; Liu Y; Li J Mol Biosyst; 2017 Jul; 13(8):1597-1607. PubMed ID: 28671703 [TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736 [TBL] [Abstract][Full Text] [Related]
18. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
19. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer. Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683 [TBL] [Abstract][Full Text] [Related]
20. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer. Segovia C; Martínez-Fernández M; Dueñas M; Rubio C; López-Calderón FF; Costa C; Saiz-Ladera C; Fernández-Grajera M; Duarte J; Muñoz HG; de la Rosa F; Villacampa F; Castellano D; Paramio JM Oncotarget; 2017 Feb; 8(6):10531-10542. PubMed ID: 28060766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]